Searchable abstracts of presentations at key conferences in endocrinology

ea0026oc1.3 | Thyroid/Adrenal | ECE2011

Maternal thyroid dysfunction during pregnancy and thyroid function of the offspring at the age of 16 years

Pakkila Fanni , Mannisto Tuija , Bloigu Aini , Vaarasmaki Marja , Hartikainen Anna-Liisa , Ruokonen Aimo , Pouta Anneli , Jarvelin Marjo-Riitta , Surcel Helja-Marja , Suvanto Eila

Introduction: Foetus is dependent on maternal thyroid hormone production during the first trimester. Thus, maternal thyroid dysfunction and thyroid antibodies may affect thyroid function of the offspring.Subjects and methods: We studied a subcohort (n=2000 mother–child-pairs) from a prospective population-based Northern Finland Birth Cohort 1986 (singleton births, total n=9247) covering data throughout pregnancy, childhood and adolesce...

ea0049gp76 | Diabetes & complications 1 | ECE2017

Increased risk of diabetes and hyperglycaemia associated with treatment with statins, beta-blockers and diuretics: the PPP-Botnia study

Hakaste Liisa , Helkkula Teo , Isomaa Bo , Taskinen Marja-Riitta , Groop Leif , Tuomi Tiinamaija

Background: Statin medication is commonly used in prevention of cardiovascular diseases. Pooled evidence shows that statin therapy is associated with increased risk of incident diabetes, but studies vary in results and there is no consensus of the diabetogenic mechanism of statins. Beta blockers and diuretics are commonly used antihypertensive agents that also have been shown to increase the risk of incident diabetes. Our objective was to examine the effects of statins, beta b...

ea0032p14 | Adrenal cortex | ECE2013

New diagnostic methods for primary aldosteronism with specific antibodies

Volpe Cristina , Hoog Anders , Ogishima Tadashi , Mukai Kuniaki , Hamberger Beril , Thoren Marja

Background: Among patients diagnosed with primary aldosteronism (PA) due to an aldosterone producing adenoma (APA), about 10% fail to normalize aldosterone hypersecretion after unilateral adrenalectomy, and may instead have bilateral aldosterone producing hyperplasia. With routine histopathology it may be difficult to distinguish between APA and hyperplasia. We have recently reported the use of specific antibodies to identify the source of aldosterone excess in the removed adr...

ea0022p28 | Adrenal | ECE2010

Predictors for cure and normotension after adrenalectomy for primary aldosteronism

Volpe Cristina , Thoren Marja , Backdahl Martin , Calissendorff Jan , Falhammar Henrik , Wahrenberg Hans , Hamberger Bertil , Enberg Ulla

Background: Primary aldosteronism (PA) accounts for 5–10% of all hypertension. In about 30% of PA patients the disease is unilateral caused by an adenoma or rarely unilateral hyperplasia. Cure rate from unilateral adrenalectomy, defined as normalized aldosterone secretion, is high but only 30–35% will obtain complete resolution of hypertension. We have studied pre- and postoperative characteristics potentially important for biochemical cure and normotension after adr...

ea0099ep548 | Reproductive and Developmental Endocrinology | ECE2024

Beyond the surface: endocrinological implications of thoracic endometriosis syndrome

Czapla-Iskrzycka Aleksandra , Pietrzak Katarzyna , Świątkowska-Stodulska Renata , Marjański Tomasz

Introduction: Thoracic Endometriosis Syndrome (TES) is characterized by clinical symptoms associated with menstruation (eg, catamenial pneumothorax (CP), chest pain, and others) not obligatorily requiring histological confirmation. The treatment is burdened with frequent recurrences. This study aimed to characterize the treatment of women with TES and assess the concomitant diseases.Methods: A developed online survey was published in patients’ suppo...

ea0049ep1285 | Thyroid (non-cancer) | ECE2017

Improved diagnostics with increased treatment of hypothyroidism during pregnancy – a 10 year study of Finnish pregnant women

Turunen Suvi , Mannisto Tuija , Hartikainen Anna-Liisa , Gissler Mika , Lahesmaa-Korpinen Anna-Maria , Vaarasmaki Marja , Suvanto Eila

Thyroid diseases affect up to 4% of all pregnancies. Several evidence-based recommendations have been created to observe and treat thyroid diseases in pregnant women. We studied whether the diagnostics and treatment of hypothyroidism among pregnant women have improved in the course of time. Data consisted of all singleton pregnancies (N=571785) during 2004–2013 in Finland, collected from the Finnish Medical Birth Register (MBR). Data on maternal thyroid diseases ...

ea0056gp165 | Paediatrics, Developmental ' Female Reproduction | ECE2018

Early childhood BMI rise, the adiposity rebound, associates with PCOS diagnosis and obesity at ages 31 and 46 years – analysis of 46-year growth data from birth to adulthood in PCOS

Koivuaho Emilia , Laru Johanna , Jokelainen Jari , Ojaniemi Marja , Puukka Katri , Ruokonen Aimo , Kettunen Johannes , Tapanainen Juha , Franks Stephen , Jarvelin Marjo-Riitta , Morin-Papunen Laure , Sebert Sylvain , Piltonen Terhi

Background: The age at adiposity rebound (AR), at which BMI begins to rise after infancy around the age of 5 years, is associated with obesity and metabolic alteration in later life. Given that polycystic ovary syndrome (PCOS) has strong metabolic components, early growth patterns could reveal predisposition for PCOS. Thus, we aimed to investigate the associations of growth trajectories from birth to puberty with PCOS diagnosis,vbody composition and hyperandrogenism later in a...

ea0054is4 | (1) | NuclearReceptors2018

Estrogen receptor cistromics in breast tumors: from biomarkers to novel drug targets

Flach Koen Dorus , Periyasamy Manikandan , Jadhav Ajit , Hickey Theresa E , Opdam Mark , Patel Hetal , Canisius Sander , Wilson David M , Dorjsuren Dorjbal , Nieuwland Marja , Kluin Roel , Zakharov Alexey V , Wesseling Jelle , Wessels Lodewyk Frederik Ary , Linn Sabine Charlotte , Tilley Wayne D , Simeonov Anton , Ali Simak , Zwart Wilbert

Estrogen receptor α (ERα) is a key transcriptional regulator in the majority of breast cancers. ERα-positive patients are frequently treated with tamoxifen, but resistance is common. Through ChIP-seq analyses, we presviously identified direct target genes of ERα acting in complex with SRC1, SRC2 or SRC3 (Zwart et al., 2011 EMBO J). Only the 111 genes there were under direct control of ERα in conjunction with SRC3 (but not the other two p160s) predicted...

ea0057021 | Cardiovascular complications in pituitary gigantism (results of an international study) | BES2018

Cardiovascular complications in pituitary gigantism (results of an international study)

Liliya Rostomyan , Adrian Daly , Nalini Shah , Luciana A Naves , Anne Barlier , Marie-Lise Jaffrain-Rea , Philippe Emy , Sebastian Neggers , Lecumberri Santamaria Beatriz , Ian Holdaway , Thierry Brue , Gunter Stalla , Roberto Salvatori , Yves Bertherat Jerome , Dominique Maiter , Margaret Zacharin , Anurag Lila , Silvia Filipponi , Satinath Mukhopadhyay , Tapani Ebeling , Marja Ojaniemi , I McCormack Ann , Outi Kuismin , Anne-Lise Lecoq , Mona Sahnoun-Fathallah , Caroline Jung-Sievers , Elena Malchiodi , Liudmila Rozhinskaya , Elena Nazzari , Sachin Mittal , Elisa Verrua , Ekaterina Sorkina , Alexander Dreval , France Devuyst , Ismene Bilbao , Simona Auriemma Renata , Palacios Garcia Nuria , Irena Ilovaiskaya , Vyacheslav Pronin , Annamaria Colao , Diego Ferone , Anna Spada , Patrick Petrossians , Paolo Beck-Peccoz , A Stratakis Constantine , Philippe Chanson , Albert Beckers

Background: Cardiovascular disease is an important cause of morbidity/mortality in chronic GH hypersecretion.Aim: To evaluate cardiovascular system in a large series of patients with pituitary gigantism. Standard case report forms were used with height assessments related to local country norms. Results: 151pts (123 male) with GH-excess and abnormal growth velocity for age or final height >2SD over local norms had complete data on cardiac assessments...